Overview
N-acetyl-L-cysteine (NAC) is a modified form of the amino acid cysteine and serves as a precursor to glutathione, the body's primary intracellular antioxidant. It exerts multiple biological effects, including potent mucolytic, antioxidant, and anti-inflammatory actions. NAC has well-established use in acetaminophen (paracetamol) overdose by replenishing hepatic glutathione stores and detoxifying reactive metabolites [3]. Beyond this, emerging evidence supports its role in modulating oxidative stress and inflammation in respiratory conditions such as chronic obstructive pulmonary disease, acute lung injury, and even in viral infections like COVID-19, where redox imbalance contributes to tissue damage [4][7]. NAC also shows promise in psychiatric and neurological conditions, including obsessive-compulsive disorder (OCD), where it modulates glutamatergic neurotransmission via the cystine-glutamate antiporter [6]. Additionally, preclinical and clinical studies suggest protective effects against pesticide-induced toxicity and endometriosis by reducing cellular proliferation and promoting a less inflammatory phenotype, without adverse effects on fertility [2][5]. Despite its widespread use, the natural occurrence of NAC in dietary sources such as Allium species remains controversial and unproven [1].
Dosage Guide
Therapeutic Doses
For treatment of specific conditions
Upper Intake Limit
Maximum safe daily intake
3000 mg— Up to 3 g/day well-tolerated in clinical trials; higher doses may cause GI side effects
Special Forms
Alternative forms for specific needs
General antioxidant support, psychiatric and respiratory indications
Acetaminophen overdose, hospital settings
Mucolytic in cystic fibrosis and chronic lung diseases
Clinical Notes
- NAC may cause gastrointestinal side effects (nausea, diarrhea) at doses above 1.2 g/day
- Theoretical risk of promoting oxidative stress in certain cancer environments; caution in active malignancy
- May interact with nitroglycerin and other nitrate medications, causing hypotension
- IV NAC can cause anaphylactoid reactions; slow infusion recommended
- Long-term high-dose use should be monitored for potential insulin resistance and altered redox signaling
Research
NAC is unlikely to be a naturally occurring compound in plants, challenging its classification as a dietary supplement ingredient.
NAC reduces proliferation and inflammation in endometrial cells, supporting its therapeutic use in endometriosis without affecting fertility.
NAC acts as a glutathione precursor, critical in acetaminophen overdose, and has been studied for antioxidant effects in various clinical settings.
Early NAC administration may reduce oxidative stress and inflammation in acute lung injury and ARDS, including in pneumonia and COVID-19.
NAC demonstrates protective effects against pesticide-induced oxidative stress in multiple organs.
3 g/day of NAC for 16 weeks showed safety and potential efficacy in reducing OCD symptoms in a randomized controlled trial.
NAC may mitigate lung injury in COVID-19 by restoring glutathione levels and scavenging reactive oxygen species.
Intravenous NAC (100 mg/kg) administered around coronary surgery did not significantly improve renal outcomes compared to placebo in a small RCT.
